News

Elizabeth Monroy is studying frogs to find ways to decrease application of post-harvest fungicides in citrus crops

The frog's skin microbiome holds the keys to controlling at least some of the most feared harvest-attacking fungi

Remember the tales of witches and wizards, using frog skins for their magic potions?

They may not have been that much off from modern biotech. The story is one of opportunities in adversity: Climate Change is threatening tropical amphibian populations because it promotes the spread of chytridiomycosis, an aggressive skin infection caused by a particular group of fungi. Research into this pathology established that specific consortia in amphibian skin microbiomes can slow or stop fungal growth. Mexican fellow Elizabeth Monroy went to Argentina to hone her genomics formation as part of Dr. Julian Dib's team at CONICET's Planta Piloto de Procesos Industriales Microbiológicos, delving into the applicability of these microbiological consortia to do the same for citrus fruit, which are aggressively attacked by opportunistic fungi after harvest, thus decimating agricultural outputs while on transit to markets. 
Until now, the way to manage this problem has been to apply chemical fungicides that are highly toxic to the environment, farmers, and consumers. We also thank Dr. Mario Alberto Serrano Ortega at Universidad Nacional Autónoma de México for collaborating in this fellowship project. 

 

 

 

Elizabeth monroy during her fellowship at proimi
elizabeth monroy inoculating lemmons

Related content

News

Joining Efforts for a Common and Effective Strategy Against Chagas and NTDs

DNDi is bringuing Latin America together to push past the early stages of development of therapies against neglected diseases

06 Aug 2026

Project

Innovation for African Farming Systems

Co-developing innovations for sustainable land management in West African smallholder farming systems (COINS) supports climate-resilient agriculture.

31 Jul 2026

News

Reverse to Break Through

Dr. Pilar Moreno led an advanced training in reverse genetics for Latin American scientists to engineer RNA viruses for vaccines and cancer therapy.

28 Jul 2026